Soleno Therapeutics to Participate in Upcoming September Conferences

Group 1 - Soleno Therapeutics, Inc. will participate in several investor conferences in September 2025, including the Cantor Global Healthcare Conference and Wells Fargo Healthcare Conference [1] - The presentation format for all listed conferences will be a fireside chat, allowing for an interactive discussion [1] - Replays of the Cantor and Wells Fargo events will be available on the company's website for investors [1] Group 2 - Soleno Therapeutics focuses on developing and commercializing novel therapeutics for rare diseases [2] - The company's first commercial product, VYKAT™ XR, is an oral treatment for hyperphagia in individuals with Prader-Willi syndrome, available for adults and children aged 4 and older [2] - For further information, the company provides resources on its website [2]